AdjuTec Pharma is preparing the company’s First-in-Human phase I clinical trial. The Norwegian start-up company AdjuTec Pharma has developed a new antibiotic product in the fight against antimicrobial resistance (AMR), which is now ready to be tested in humans. The final product will be administered intravenously to severely ill patients infected with bacteria resistant to existing treatments. AMR is a …